Long-acting bronchodilators in premenstrual exacerbation of asthma

Respiratory Medicine

Volumn 95, Issue 9, 2001, Pages 740-743

  Magadle, R ^a   Berar Yanay, N ^a   Weiner, P ^a  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

Author keywords

Asthma; Deterioration; LABD; PME

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; GLUCOCORTICOID; LONG ACTING DRUG; PLACEBO; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TIME;

EID: 0034804149     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2001.1132     Document Type: Article

References (16)

1. Premenstrual exacerbation of asthma
2. Premenstrual symptoms in women with premenstrual asthma
3. The effect of the menstrual cycle on asthma presentations in the emergency department
4. 2-receptors
5. Influence of the menstrual cycle on systemic disease
6. Gonadotropin releasing hormone analogues: A novel treatment for premenstrual asthma
7. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
8. Influence of the menstrual cycle on airway function in asthmatic and normal subjects
9. Modulation of airway reactivity and peak flow variability in asthmatics receiving the oral contraceptive pill
10. Severe premenstrual exacerbation of asthma: Effect of intramuscular progesterone
11. Should supplemental estrogens be used as steroid sparing agents in asthmatic women?
12. Do hormonal contraceptives influence asthma severity?
13. Subclinical worsening of bronchial asthma during estrogen replacement therapy in asthmatic postmenopausal women
14. Possible asthmogenic effect of oral contraceptives
15. Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis
16. Added salmeterol versus higher dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid